Chenxi Liu1, Shengzhong Wang2, Xiaocheng Wei3, Gang Xiao1, YUchuan Hu1, and Guangbin Cui1
1Tangdu Hospital, Air Force Medical University, Xi'an, China, 2Shaanxi University of Traditional Chinese Medicine, Xi'an, China, 3GE Healthcare, Beijing, China
Synopsis
The pathological staging system of Thymic
epithelial tumors (TETs) which called Masaoka staging, is an important
prognostic factor, and its impact on survival is much greater than that of WHO
classification. However, as the Masaoka stage can only be established
postoperatively, preoperative imaging has important implications concerning
treatment strategy. This study analyzes the differences of T1 values and ADC values
in different regions, different types and stages of TETs tumors, and
establishes a reliable noninvasive imaging technology to distinguish the risk
classification and stage of tumors.
Abstract
Target audience Radiologist: surgeon and clinicians interested in thymic tumor.
Introduction Thymic epithelial tumors (TETs) include a heterogeneous group of tumors
ranging from nearly benign thymomas to aggressive thymic carcinomas. The
pathological staging system based on intraoperative findings, including the
invasiveness of tumor capsule, invasion of surrounding tissues and organs, and
distant metastasis, called Masaoka staging, is an important prognostic factor,
and its impact on survival is much greater than that of WHO classification1,2. However,
as the Masaoka stage can only be established postoperatively, preoperative
imaging has important implications concerning treatment strategy. Preoperative
imaging provides a comprehensive view of the entire tumor and its surroundings,
and a greater degree of information may be derived by the employment of new
diagnostic imaging tools for the assessment of the tumors. Recent
studies have shown that collagen fibers play an important role in the
development and progress of TETS, and different collagen fiber bands are
closely related to the staging and prognosis of thymoma3. However,
whether quantitative collagen fibers can accurately distinguish the risk
classification and staging of TETS is unknown. T1 mapping is an emerging concept for
quantitative tissue characterization, evaluating the longitudinal relaxation
time (T1) in each image voxel and thus providing unique quantifiable and
reproducible intrinsic tissue values4. In the kidney, T1 mapping can differentiate
the cortex and medulla in the normal renal parenchyma, and the T1 relaxation
time has been shown to be a reliable marker of injury and can potentially
identify pathological changes, including edema, inflammation, and fibrosis5. This
study analyzes the differences of T1 values and ADC values in different
regions, different types and stages of TETs tumors, and establishes a reliable
noninvasive imaging technology to distinguish the risk classification and stage
of tumors, which is helpful to improve the diagnostic accuracy and provide the
best individual treatment for patients.
Method This single-center retrospective study was approved by
the Ethics Committee of Tangdu Hospital of the Fourth Military Medical
University, and informed consent was waived. Forty-nine patients with TETs confirmed by the pathological
analysis were included in this study. All preoperative MRI examinations were
performed using a 3.0-T whole-body system (MR750, GE Healthcare, Milwaukee, WI)
with a 40-mT/m maximum gradient capability and a standard 8-channel torso coil.
The MR protocol included respiratory triggering T1-weighted spin-echo in the
axial plane, T2-weighted fast spin echo in the axial and coronal planes, and
axial fat-suppressed T2-weighted turbo spin-echo images (FS-T2WI).
Subsequently, DWI sequences (b = 1000 s/mm2) were performed with a
single-shot diffusion-weighted spin-echo echo-planar sequence. In addition, we
received native and respiratory gated steady-state precession readout
single-shot Modified Look-Locker Inversion Recovery (MOLLI) sequences in axial
planes of the tumors. The native T1 and ADC values were compared for
differences among low-risk thymomas (LRT), high-risk thymomas (HRT), and thymic
carcinomas (TC) and for differences between early and advanced stage TETs based
on one-way ANOVA and independent sample t-test, respectively. Receiver
operating characteristic curve (ROC) analyses were performed to determine
optimum thresholds for differentiating the defined subtypes or stages by native
T1 and apparent diffusion coefficient (ADC) values, and also to calculate the
sensitivity, specificity, and area under the curve (AUC).
Results According
to the WHO pathological classification, 26 (53.1%) patients had LRT (4 had
types A thymoma, 16 had types AB thymoma, and 6 had types B1 thymoma), 7 (14.3%)
had HRT (6 had types B1 thymoma and 1 had types B3 thymoma) and 14 (28.6%) had
TC. As shown in Table 1 and Figure 1, the native T1 and ADC values in thymoma
were significantly higher than the values from TC (all P < 0.01), while
there were no significant differences between the LRT and HRT (P﹥0.05). Also, in the early stage, values were significantly higher than
ones in the advanced stage of TETs (P < 0.01). The correlation diagram
between native T1 value and ADC values of TETs shows a positive correlation
(Figure 2). Based on the ROC analyses, the native T1 value achieved the higher
diagnostic efficacy in differentiating thymoma from TC, with an AUC of 0.831,
the sensitivity and specificity were 53.3% and 100.0%, respectively. For differentiating early from
advanced stages of TETs, ADC value achieved the higher diagnostic efficacy with
an AUC of 0.829. Furthermore, a combination of native T1 and ADC achieved the
higher differentiating ability for differentiating both the defined simplified
subtype and stage of TETs (Figure 3).
Discussion In this
study, we evaluated the significance of native T1 and apparent diffusion
coefficient (ADC) values in differentiating the defined groups of thymic
epithelial tumors (TETs) based on the WHO classification and Masaoka-Koga
stage. Our study obtained a good performance in differentiating these groups.
Conclusion Combination of native T1 and ADC values
improved the differentiating ability of TET grades, which could potentially be
useful in clinical practice regarding the TET evaluation before treatment.Acknowledgements
We would like to
thank Dr. Xiao-Cheng Wei in GE Healthcare China for providing technical support
regarding the appropriate applied MRI sequence. This work was supported by the
Science and Technology Innovation Development Foundation of Tangdu Hospital
(No. 2017LCYJ004)
Our article didn't received funding for research from
any of the following organizations: National Institutes of Health (NIH),
Wellcome Trust, Howard Hughes Medical Institute (HHMI).
References
1. Thymic epithelial tumors: prognostic
determinants among clinical, histopathologic, and computed tomography findings.
2. Ried
M, Marx A, Götz A, Hamer O, Schalke B, Hofmann HS. State of the art: diagnostic
tools and innovative therapies for treatment of advanced thymoma and tymic
carcinoma. Eur J Cardiothorac Surg. 2016;49(6):1545-1552.
3. Minami
K, Jimbo N, Tanaka Y, et al. Fibrous bands associated with higher Masaoka stage
and poor recurrence-free survival in patients with thymoma. Thorac Cancer.
2021;12(3):349-356.
4. aylor AJ, Salerno M,
Dharmakumar R, et al. T1 mapping: basic techniques and clinical applications.
JACC Cardiovasc Imaging.2016;9:67–81.
5.
Wang S, Li J, Zhu D, Hua
T, Zhao B. Contrast-enhanced magnetic resonance (MR) T1 mapping with low-dose
gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is promising in
identifying clear cell renal cell carcinoma histopathological grade and differentiating
fat-poor angiomyolipoma. Quant Imaging Med Surg 2020; 10:988-998.